SEC Form 4 · accession 0001209191-18-036127
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eilon D. Kirson
Officer — Chief Science Officer
Period of report
Jun 4, 2018
Accepted (ET)
Jun 6, 2018 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 4, 2018 | M | 218,781 | $7.03 | A | 258,363 | D | |
| Ordinary SharesF1 | Jun 4, 2018 | S | 225,296 | $28.60 | D | 33,067 | D | |
| Ordinary Shares | Jun 4, 2018 | M | 59,130 | $7.48 | A | 92,197 | D | |
| Ordinary Shares | Jun 4, 2018 | M | 68,250 | $7.15 | A | 160,447 | D | |
| Ordinary SharesF2 | Jun 4, 2018 | S | 114,934 | $29.36 | D | 45,513 | D | |
| Ordinary SharesF3 | Jun 4, 2018 | S | 1,800 | $30.26 | D | 43,713 | D | |
| Ordinary SharesF4 | Jun 4, 2018 | S | 4,131 | $31.74 | D | 39,582 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF5 | $7.03 | Jun 4, 2018 | M | 218,781 | A | — | Feb 19, 2023 | Ordinary Shares | 218,781 | 0 | D |
| Options to Buy Ordinary SharesF5 | $7.48 | Jun 4, 2018 | M | 59,130 | A | — | Feb 25, 2024 | Ordinary Shares | 59,130 | 0 | D |
| Options to Buy Ordinary SharesF5 | $7.15 | Jun 4, 2018 | M | 68,250 | A | — | Feb 21, 2027 | Ordinary Shares | 68,250 | 204,750 | D |
Explanation of responses
- F1On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 225,296 shares in multiple trades at prices ranging from $28.00 to $28.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F2On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 114,934 shares in multiple trades at prices ranging from $29.00 to $29.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F3On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 1,800 shares in multiple trades at prices ranging from $30.00 to $30.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F4On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 4,131 shares in multiple trades at prices ranging from $31.00 to $31.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F5Options exercised were fully vested as of the date hereof.